Search Results - "McIntyre, Rebecca L"

  • Showing 1 - 19 results of 19
Refine Results
  1. 1

    From molecular promise to preclinical results: HDAC inhibitors in the race for healthy aging drugs by McIntyre, Rebecca L, Daniels, Eileen G, Molenaars, Marte, Houtkooper, Riekelt H, Janssens, Georges E

    Published in EMBO molecular medicine (01-09-2019)
    “…Reversing or slowing the aging process brings great promise to treat or prevent age‐related disease, and targeting the hallmarks of aging is a strategy to…”
    Get full text
    Journal Article
  2. 2

    Glycine promotes longevity in Caenorhabditis elegans in a methionine cycle-dependent fashion by Liu, Yasmine J, Janssens, Georges E, McIntyre, Rebecca L, Molenaars, Marte, Kamble, Rashmi, Gao, Arwen W, Jongejan, Aldo, Weeghel, Michel van, MacInnes, Alyson W, Houtkooper, Riekelt H

    Published in PLoS genetics (07-03-2019)
    “…The deregulation of metabolism is a hallmark of aging. As such, changes in the expression of metabolic genes and the profiles of amino acid levels are features…”
    Get full text
    Journal Article
  3. 3
  4. 4

    Integrating the Hallmarks of Aging Throughout the Tree of Life: A Focus on Mitochondrial Dysfunction by van der Rijt, Sanne, Molenaars, Marte, McIntyre, Rebecca L, Janssens, Georges E, Houtkooper, Riekelt H

    “…Since the identification and definition of the hallmarks of aging, these aspects of molecular and cellular decline have been most often described as isolated…”
    Get full text
    Journal Article
  5. 5
  6. 6

    Considerations Regarding Public Use of Longevity Interventions by Liu, Yasmine J, McIntyre, Rebecca L, Janssens, Georges E

    Published in Frontiers in aging (25-04-2022)
    “…Public attention and interest for longevity interventions are growing. These can include dietary interventions such as intermittent fasting, physical…”
    Get full text
    Journal Article
  7. 7

    Biological Age Prediction From Wearable Device Movement Data Identifies Nutritional and Pharmacological Interventions for Healthy Aging by McIntyre, Rebecca L., Rahman, Mizanur, Vanapalli, Siva A., Houtkooper, Riekelt H., Janssens, Georges E.

    Published in Frontiers in aging (15-07-2021)
    “…Intervening in aging processes is hypothesized to extend healthy years of life and treat age-related disease, thereby providing great benefit to society…”
    Get full text
    Journal Article
  8. 8

    Low-dose naltrexone extends healthspan and lifespan in C. elegans via SKN-1 activation by Li, Weisha, McIntyre, Rebecca L., Schomakers, Bauke V., Kamble, Rashmi, Luesink, Anne H.G., van Weeghel, Michel, Houtkooper, Riekelt H., Gao, Arwen W., Janssens, Georges E.

    Published in iScience (21-06-2024)
    “…As the global aging population rises, finding effective interventions to improve aging health is crucial. Drug repurposing, utilizing existing drugs for new…”
    Get full text
    Journal Article
  9. 9

    Mitochondrial fission and fusion: A dynamic role in aging and potential target for age-related disease by Liu, Yasmine J., McIntyre, Rebecca L., Janssens, Georges E., Houtkooper, Riekelt H.

    Published in Mechanisms of ageing and development (01-03-2020)
    “…•Mitochondrial fission and fusion are implicated in age-related human pathologies.•Crucial to mitochondrial regulation is their dynamic nature in a network…”
    Get full text
    Journal Article
  10. 10
  11. 11
  12. 12

    Repurposing nucleoside reverse transcriptase inhibitors (NRTIs) to slow aging by Brochard, Thomas, McIntyre, Rebecca L, Houtkooper, Riekelt H, Seluanov, Andrei, Gorbunova, Vera, Janssens, Georges E

    Published in Ageing research reviews (01-12-2023)
    “…Repurposing drugs already approved in the clinic to be used off-label as geroprotectors, compounds that combat mechanisms of aging, are a promising way to…”
    Get full text
    Journal Article
  13. 13
  14. 14

    Pharmaceutical and nutraceutical activation of FOXO3 for healthy longevity by McIntyre, Rebecca L., Liu, Yasmine J., Hu, Man, Morris, Brian J., Willcox, Bradley J., Donlon, Timothy A., Houtkooper, Riekelt H., Janssens, Georges E.

    Published in Ageing research reviews (01-06-2022)
    “…Life expectancy has increased substantially over the last 150 years. Yet this means that now most people also spend a greater length of time suffering from…”
    Get full text
    Journal Article
  15. 15
  16. 16
  17. 17

    Akt and mTORC1 Have Different Roles During Liver Tumorigenesis in Mice by Kenerson, Heidi L, Yeh, Matthew M, Kazami, Machiko, Jiang, Xiuyun, Riehle, Kimberly J, McIntyre, Rebecca L, Park, James O, Kwon, Steve, Campbell, Jean S, Yeung, Raymond S

    Published in Gastroenterology (New York, N.Y. 1943) (01-05-2013)
    “…Background & Aims Phosphatidylinositide 3-kinase (PI3K) is deregulated in many human tumor types, including primary liver malignancies. The kinase v-akt murine…”
    Get full text
    Journal Article
  18. 18

    Polybrominated diphenyl ether congener, BDE-47, impairs insulin sensitivity in mice with liver-specific Pten deficiency by McIntyre, Rebecca L, Kenerson, Heidi L, Subramanian, Savitha, Wang, Shari A, Kazami, Machiko, Stapleton, Heather M, Yeung, Raymond S

    Published in BMC obesity (07-02-2015)
    “…The potential health effects of polybrominated diphenyl ethers (PBDEs) that are widely used as flame-retardants in consumer products have been attributed, in…”
    Get full text
    Journal Article
  19. 19